New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:03 EDTANIPANI Pharmaceuticals enters development agreement with Sterling Pharmaceutical
ANI Pharmaceuticals announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services. The product will be developed by Sterling and transferred into ANI's facilities for commercial manufacture and marketing. The current annual market for this product is $60M, according to IMS Health.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
17:51 EDTANIPS&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices
Subscribe for More Information
17:24 EDTANIPANI Pharmaceuticals to replace Gentiva Health in S&P 600 as of 2/2 close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use